These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 7718417)

  • 41. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
    Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
    Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.
    Csernok E; Schmitt WH; Ernst M; Bainton DF; Gross WL
    Adv Exp Med Biol; 1993; 336():45-50. PubMed ID: 8296655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.
    Ohlsson S; Wieslander J; Segelmark M
    Clin Exp Immunol; 2003 Mar; 131(3):528-35. PubMed ID: 12605707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies.
    Reumaux D; Vossebeld PJ; Roos D; Verhoeven AJ
    Blood; 1995 Oct; 86(8):3189-95. PubMed ID: 7579414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Kallenberg CG; Rarok A; Stegeman CA; Limburg PC
    Autoimmun Rev; 2002 Feb; 1(1-2):61-6. PubMed ID: 12849060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Wegener's granulomatosis and ANCA-associated vasculitis: pathogenic role of autoantigens, autoantibodies, and cytokines].
    Kekow J; Csernok E; Szymkowiak CH; Gross WL
    Immun Infekt; 1993 Apr; 21 Suppl 1():44-8. PubMed ID: 8344692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies.
    Surmiak M; Kaczor M; Sanak M
    J Physiol Pharmacol; 2012 Jun; 63(3):249-56. PubMed ID: 22791638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of proteinase 3-anti-neutrophil cytoplasmic autoantibodies by proteinase 3-homologous bacterial protease in mice.
    Kim YC; Choi YS; Alam J; Kim YJ; Baek KJ; Koh J; Song YW; Chung DH; Choi Y
    Immunol Res; 2016 Apr; 64(2):438-44. PubMed ID: 26318749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.
    Savige JA; Chang L; Cook L; Burdon J; Daskalakis M; Doery J
    Clin Exp Immunol; 1995 May; 100(2):194-7. PubMed ID: 7743654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.
    Gross WL; Schmitt WH; Csernok E
    Am J Kidney Dis; 1991 Aug; 18(2):175-9. PubMed ID: 1867175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anti-cytoplasmic antibodies of polynucle or "ANCA". A new class of autoantibodies].
    Noël LH
    Rev Prat; 1992 Jun; 42(12):1534-9. PubMed ID: 1411180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation.
    Schultz DR; Diego JM
    Semin Arthritis Rheum; 2000 Apr; 29(5):267-85. PubMed ID: 10805352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in pathogenesis and treatment of ANCA-associated vasculitis.
    Kallenberg CG
    Discov Med; 2014 Oct; 18(99):195-201. PubMed ID: 25336033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvement.
    Dringenberg C; Apenberg S; Andrassy K
    Adv Exp Med Biol; 1993; 336():445-7. PubMed ID: 8296653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models.
    Kain R; Firmin DA; Rees AJ
    Curr Opin Rheumatol; 2010 Jan; 22(1):15-20. PubMed ID: 19823088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase.
    Gaudin PB; Askin FB; Falk RJ; Jennette JC
    Am J Clin Pathol; 1995 Jul; 104(1):7-16. PubMed ID: 7611186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What you should know about PR3-ANCA. An introduction.
    Wiik A
    Arthritis Res; 2000; 2(4):252-4. PubMed ID: 11094436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of autoantibodies to purified proteinase 3 in systemic vasculitis.
    Gaskin G; Turner AN; Ryan JJ; Rees AJ; Pusey CD
    Adv Exp Med Biol; 1993; 336():287-9. PubMed ID: 8296619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis.
    Gaskin G; Kendal H; Coulthart A; Turner N; Pusey CD
    J Immunol Methods; 1995 Mar; 180(1):25-33. PubMed ID: 7897245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis.
    Kyndt X; Reumaux D; Bridoux F; Tribout B; Bataille P; Hachulla E; Hatron PY; Duthilleul P; Vanhille P
    Am J Med; 1999 May; 106(5):527-33. PubMed ID: 10335724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.